Yep... exactly what I thought after reading it thank you!
Very true, but I just don’t think we are going to overhaul the clinical trial and regulatory approval system on top of trying to find a treatment...
Or statins for preventing major cardiovascular events. It could be that ok the drugs aren’t bad it’s that people taking them think ok now I don’t...
A meta-analysis review worth reading, giving pause to how truly (in)effective many common FDA approved are compared to placebo. How effective are...
Isn’t it true for most (if not close to all) FDA approved drugs, that during their successful phase III trials that were key to their regulatory...
If you went up in dosage I would expect it to cause sleep difficulties again until it normalizes?
Going back to Abilify and potential pathphysiological mechantistic clues… Here’s a question, let suppose that the theory that the core pathology...
I've been trying to tell Janet Dafoe and Ron via PR about brilaroxazine. To me so far in phase 1 and 2 clinical trials and other published...
Im not on the FBK group but if it’s anything like the Reddit CFS group of which I’ve read I believe all the posts regarding Abilify, it’s really...
In fact, at the very low dosages pwME are taking there’s significant experimental evidence that Abilify not only stabilizes dopamine but boosts...
Did those family members take the ultra low dosage Abilify and get TD from that? Did they have ME and were taking low dose Abilify to treat it? Or...
Yes, exactly, and by A LOT.
I knew that trying to be as detailed as possible would probably get confusing. It’s really hard sometimes to describe clearly how this illness...
One aspect of my ME that Abilify appears to have little effect on is my suspected mast cell activation problems in my gut and lower abdominal skin...
The biggest difference by far I can remember, and this is a huge difference - is with the ketogenic diet after the first couple weeks, where I...
For those who are new to this thread and reading about Abilify for ME thinking, "could ME be a neuropsychiatric disorder?", the answer is no. It's...
This paper has useful pharmacological and kinetic information: RP5063, an atypical antipsychotic drug with a unique pharmacologic profile,...
Brilaroxazine (RP5063) is also being trialed by Reviva for PAH because of its effects on serotonin receptors.
Initial Clinical Experience of RP5063 Following Single Doses in Normal Healthy Volunteers and Multiple Doses in Patients with Stable Schizophrenia...
Here’s the paper on the phase 2 clinical trial results for brilaroxazine. Abilify is also an arm in the trial (powered for sensitivity not...
Separate names with a comma.